A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization.
Trinka, E; Tsong, W; Toupin, S; Patten, A; Wilson, K; Isojarvi, J; James, D
EPILEPSY RES. 2020; 166: 106403
Reviews

Influence of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials.
Krauss, G; Biton, V; Harvey, JH; Elger, C; Trinka, E; Soares da Silva, P; Gama, H; Cheng, H; Grinnell, T; Blum, D;
Epilepsy Res. 2018; 139:1-8
Full papers/articles (Journal)

Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
Biton, V; Rogin, JB; Krauss, G; Abou-Khalil, B; Rocha, JF; Moreira, J; Gama, H; Trinka, E; Elger, CE; Cheng, HL; Grinnell, T; Blum, D
Epilepsy Behav. 2017; 72:127-134
Full papers/articles (Journal)

Assessment of the efficacy and safety of eslicarbazepine acetate in acute mania and prevention of recurrence: experience from multicentre, double-blind, randomised phase II clinical studies in patients with bipolar disorder I.
Grunze, H; Kotlik, E; Costa, R; Nunes, T; Falcão, A; Almeida, L; Soares-da-Silva, P;
J Affect Disord. 2015; 174:70-82
Full papers/articles (Journal)

Flexible dosing of adjunctive zonisamide in the treatment of adult partial-onset seizures: a non-comparative, open-label study (ZEUS).
Dupont, S; Striano, S; Trinka, E; Springub, J; Giallonardo, AT; Smith, P; Ellis, S; Yeates, A; Baker, G;
Acta Neurol Scand. 2010; 121(3):141-148
Full papers/articles (Journal)